The Selective Protein Kinase C β Inhibitor Enzastaurin Induces Apoptosis in Cutaneous T-Cell Lymphoma Cell Lines through the AKT Pathway

This publication has 27 references indexed in Scilit:

• Expression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell lymphoma
  Laboratory Investigation, 2005
• Inhibition of Phosphatidylinositol 3′-Kinase/AKT Signaling Promotes Apoptosis of Primary Effusion Lymphoma Cells
  Clinical Cancer Research, 2005
• Inhibition of phosphatidylinositol 3′-kinase induces preferentially killing of PTEN-null T leukemias through AKT pathway
  Biochemical and Biophysical Research Communications, 2004
• UCN‐01 alters phosphorylation of Akt and GSK3β and induces apoptosis in six independent human neuroblastoma cell lines
  Journal of Neurochemistry, 2004
• Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy
  Leukemia, 2003
• Differential expression of protein kinase C isoenzymes related to high nitric oxide synthase activity in a T lymphoma cell line
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2002
• The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
  Nature Reviews Cancer, 2002
• Protein kinase Cθ: a new essential superstar on the T-cell stage
  Immunology Today, 2000
• PKC-θ is required for TCR-induced NF-κB activation in mature but not immature T lymphocytes
  Nature, 2000
• Involvement of Protein Kinase C-β and Ceramide in Tumor Necrosis Factor-α-induced but Not Fas-induced Apoptosis of Human Myeloid Leukemia Cells
  Published by Elsevier ,1999